# KB Home: financial statements, quarterly

KBH · NYSE · CIK 795266 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/kbh.md) · [Financials](/companies/kbh/financials.md) · [Filings](/companies/kbh/filings.md) · [Insiders](/companies/kbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kbh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,674 d](/filings/0000795266-26-000017.md) | [1,468](/filings/0000795266-25-000043.md) | [1,710](/filings/0000795266-25-000081.md) | [1,753](/filings/0000795266-25-000097.md) | [2,000 d](/filings/0000795266-26-000017.md) | [1,392](/filings/0000795266-26-000042.md) | [1,530](/filings/0000795266-26-000063.md) | [1,620](/filings/0000795266-26-000071.md) | [1,694 d](/filings/0000795266-26-000017.md) | [1,077](/filings/0000795266-26-000042.md) | [1,112](/filings/0000795266-26-000063.md) | [1,297](/filings/0000795266-26-000071.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [49.3 d](/filings/0000795266-26-000017.md) | [36.0](/filings/0000795266-25-000043.md) | [52.7](/filings/0000795266-25-000081.md) | [50.1](/filings/0000795266-25-000097.md) | [57.1 d](/filings/0000795266-26-000017.md) | [29.8](/filings/0000795266-26-000042.md) | [34.5](/filings/0000795266-26-000063.md) | [33.4](/filings/0000795266-26-000071.md) | [27.7 d](/filings/0000795266-26-000017.md) | [6.9](/filings/0000795266-26-000042.md) | [9.9](/filings/0000795266-26-000063.md) | [15.9](/filings/0000795266-26-000071.md) |
| Net income | $m | [150 d](/filings/0000795266-26-000017.md) | [139](/filings/0000795266-25-000043.md) | [168](/filings/0000795266-25-000081.md) | [157](/filings/0000795266-25-000097.md) | [191 d](/filings/0000795266-26-000017.md) | [110](/filings/0000795266-26-000042.md) | [108](/filings/0000795266-26-000063.md) | [110](/filings/0000795266-26-000071.md) | [102 d](/filings/0000795266-26-000017.md) | [33.4](/filings/0000795266-26-000042.md) | [27.3](/filings/0000795266-26-000063.md) | [65.3](/filings/0000795266-26-000071.md) |
| Diluted EPS | $ per share | not reported | [1.76](/filings/0000795266-25-000043.md) | [2.15](/filings/0000795266-25-000081.md) | [2.04](/filings/0000795266-25-000097.md) | not reported | [1.49](/filings/0000795266-26-000042.md) | [1.50](/filings/0000795266-26-000063.md) | [1.61](/filings/0000795266-26-000071.md) | not reported | [0.52](/filings/0000795266-26-000042.md) | [0.43](/filings/0000795266-26-000063.md) | [1.05](/filings/0000795266-26-000071.md) |
| Basic EPS | $ per share | not reported | [1.81](/filings/0000795266-25-000043.md) | [2.21](/filings/0000795266-25-000081.md) | [2.10](/filings/0000795266-25-000097.md) | not reported | [1.52](/filings/0000795266-26-000042.md) | [1.53](/filings/0000795266-26-000063.md) | [1.64](/filings/0000795266-26-000071.md) | not reported | [0.53](/filings/0000795266-26-000042.md) | [0.44](/filings/0000795266-26-000063.md) | [1.07](/filings/0000795266-26-000071.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Selling, general and administrative: not reported
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [6,648](/filings/0000795266-25-000014.md) | [6,683](/filings/0000795266-24-000060.md) | [6,806](/filings/0000795266-24-000100.md) | [6,840](/filings/0000795266-24-000119.md) | [6,936](/filings/0000795266-26-000017.md) | [6,979](/filings/0000795266-25-000043.md) | [7,018](/filings/0000795266-25-000081.md) | [6,986](/filings/0000795266-25-000097.md) | [6,680](/filings/0000795266-26-000071.md) | [6,703](/filings/0000795266-26-000042.md) | [6,775](/filings/0000795266-26-000063.md) | [6,969](/filings/0000795266-26-000071.md) |
| Shareholders' equity | $m | [3,810](/filings/0000795266-26-000017.md) | [3,883](/filings/0000795266-25-000081.md) | [3,992](/filings/0000795266-25-000097.md) | [3,987](/filings/0000795266-25-000097.md) | [4,061](/filings/0000795266-26-000071.md) | [4,093](/filings/0000795266-26-000063.md) | [3,991](/filings/0000795266-26-000071.md) | [3,902](/filings/0000795266-26-000071.md) | [3,901](/filings/0000795266-26-000071.md) | [3,855](/filings/0000795266-26-000063.md) | [3,797](/filings/0000795266-26-000071.md) | [3,802](/filings/0000795266-26-000071.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [310 d](/filings/0000795266-26-000017.md) | [28.5](/filings/0000795266-25-000043.md) | [61.5 d](/filings/0000795266-25-000081.md) | [(89.9) d](/filings/0000795266-25-000097.md) | [363 d](/filings/0000795266-26-000017.md) | [(334)](/filings/0000795266-26-000042.md) | [168 d](/filings/0000795266-26-000063.md) | [198 d](/filings/0000795266-26-000071.md) | [304 d](/filings/0000795266-26-000017.md) | [(125)](/filings/0000795266-26-000042.md) | [31.9 d](/filings/0000795266-26-000063.md) | [(135) d](/filings/0000795266-26-000071.md) |
| Capital expenditure | $m | [9.1 d](/filings/0000795266-26-000017.md) | [9.5](/filings/0000795266-25-000043.md) | [10.3 d](/filings/0000795266-25-000081.md) | [9.5 d](/filings/0000795266-25-000097.md) | [10.1 d](/filings/0000795266-26-000017.md) | [11.2](/filings/0000795266-26-000042.md) | [11.5 d](/filings/0000795266-26-000063.md) | [11.9 d](/filings/0000795266-26-000071.md) | [13.8 d](/filings/0000795266-26-000017.md) | [13.2](/filings/0000795266-26-000042.md) | [9.7 d](/filings/0000795266-26-000063.md) | [9.6 d](/filings/0000795266-26-000071.md) |
| Dividends paid | $m | [15.2 d](/filings/0000795266-26-000017.md) | [16.4](/filings/0000795266-25-000043.md) | [18.8 d](/filings/0000795266-25-000081.md) | [18.4 d](/filings/0000795266-25-000097.md) | [18.0 d](/filings/0000795266-26-000017.md) | [19.3](/filings/0000795266-26-000042.md) | [17.2 d](/filings/0000795266-26-000063.md) | [16.3 d](/filings/0000795266-26-000071.md) | [15.8 d](/filings/0000795266-26-000017.md) | [17.3](/filings/0000795266-26-000042.md) | [15.3 d](/filings/0000795266-26-000063.md) | [15.2 d](/filings/0000795266-26-000071.md) |
| Share repurchases | $m | [162 d](/filings/0000795266-26-000017.md) | [50.0](/filings/0000795266-25-000043.md) | [50.0 d](/filings/0000795266-25-000081.md) | [150 d](/filings/0000795266-25-000097.md) | [104 d](/filings/0000795266-26-000017.md) | [50.0](/filings/0000795266-26-000042.md) | [200 d](/filings/0000795266-26-000063.md) | [188 d](/filings/0000795266-26-000071.md) | [103 d](/filings/0000795266-26-000017.md) | [50.0](/filings/0000795266-26-000042.md) | [80.1 d](/filings/0000795266-26-000063.md) | [50.0 d](/filings/0000795266-26-000071.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.0](/filings/0000795266-24-000060.md) | [84.3](/filings/0000795266-24-000100.md) | [82.7](/filings/0000795266-24-000119.md) | [78.3](/filings/0000795266-25-000043.md) | [77.8](/filings/0000795266-25-000081.md) | [76.6](/filings/0000795266-25-000097.md) | [73.0](/filings/0000795266-26-000042.md) | [71.2](/filings/0000795266-26-000063.md) | [67.7](/filings/0000795266-26-000071.md) | [63.7](/filings/0000795266-26-000042.md) | [62.7](/filings/0000795266-26-000063.md) | [61.8](/filings/0000795266-26-000071.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 60,762,736 at 2026-08-31, from the cover of the [10-Q filed 2026-10-08](/filings/0000795266-26-000071.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.